Reports of cases of AIDS, HIV infection, and HIV/AIDS 1

Size: px
Start display at page:

Download "Reports of cases of AIDS, HIV infection, and HIV/AIDS 1"

Transcription

1 Reports of cses of AIDS, HIV infection, nd HIV/AIDS 1

2 The HIV/AIDS Surveillnce Report is published nnully by the Division of HIV/AIDS Prevention Surveillnce nd Epidemiology, Ntionl Center for HIV, STD, nd TB Prevention, Coordinting Center for Infectious Diseses, Centers for Disese Control nd Prevention, Atlnt, Georgi. All dt re provisionl. The HIV/AIDS Surveillnce Report is not copyrighted nd my be used nd copied without permission. Cittion of the source is, however, pprecited. Suggested cittion Centers for Disese Control nd Prevention. HIV/AIDS Surveillnce Report, Vol. 16. Atlnt: US Deprtment of Helth nd Humn Services, Centers for Disese Control nd Prevention; 2005:[inclusive pge numbers]. Also vilble t: Centers for Disese Control nd Prevention... Julie Louise Gerberding, M.D., M.P.H. Director Coordinting Center for Infectious Diseses...Mitch Cohen, M.D. Director Ntionl Center for HIV, STD, nd TB Prevention... Ronld O. Vldiserri, M.D., M.P.H. Acting Director Division of HIV/AIDS Prevention Surveillnce nd Epidemiology... Robert S. Jnssen, M.D. Director HIV Incidence nd Cse Surveillnce Brnch... Mtthew T. McKenn, M.D., M.P.H. Chief Reporting, Anlysis, nd Evlution Tem... Kte Glynn, D.V.M. Tem Supervisor Reserch nd Dissemintion Tem... Michel Cmpsmith, D.D.S., M.P.H. Tem Supervisor Sttistics nd Dt Mngement Brnch... Timothy A. Green, Ph.D. Chief Single copies: CDC Ntionl Prevention Informtion Network, P.O. Box 6003, Rockville, MD Telephone: or Request to be dded to miling list: CDC, MASO/MSB, Mil Stop F-07, 4770 Buford Highwy, Chmblee, GA On the Web: Select Publictions, Softwre & Products Confidentil informtion, referrls, nd eductionl mteril on HIV infection nd AIDS: CDC Ntionl AIDS Hotline, , (Spnish), (TTY, def ccess) Acknowledgments: Publiction of this report would not hve been possible without the contributions of the Stte nd Territoril Helth Deprtments nd the HIV/AIDS Surveillnce Progrms which provided surveillnce dt to the Centers for Disese Control nd Prevention. This report ws prepred by the following stff nd contrctors of the Division of HIV/AIDS Prevention, Ntionl Center for HIV, STD, nd TB Prevention, Centers for Disese Control nd Prevention: Jnet Brzuskiewicz, Michel Cmpsmith, Robert Frey, Kte Glynn, Xiohong Hu, Denise Hughes, Lis M. Lee, Jinmin Li, Ktrin McGhee, Mtthew McKenn, Ann Stcher, nd Lynne Stockton. The HIV/AIDS design element on the cover is used with the permission of the Americn Red Cross. Federl Recycling Progrm Printed on recycled pper 2 Reports of cses of AIDS, HIV infection, nd HIV/AIDS

3 Contents Commentry... 5 Section 1 Cses of HIV/AIDS nd AIDS Tble 1. Estimted numbers of cses of HIV/AIDS, by yer of dignosis nd selected chrcteristics of persons, res with confidentil nme-bsed HIV infection reporting Tble 2. Estimted distribution of persons with nd persons without dignosis of AIDS within 12 months of dignosis of HIV infection, by selected chrcteristics, res with confidentil nme-bsed HIV infection reporting...11 Tble 3. Estimted numbers of AIDS cses, by yer of dignosis nd selected chrcteristics of persons, United Sttes Tble 4. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis nd trnsmission ctegory, United Sttes Figure 1. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis, United Sttes Tble 5. Estimted numbers of cses nd rtes (per 100,000 popultion) of AIDS, by rce/ethnicity, ge ctegory, nd sex, sttes nd the District of Columbi Tble 5b. Estimted numbers of cses nd rtes (per 100,000 popultion) of HIV/AIDS, by rce/ethnicity, ge ctegory, nd sex, sttes with confidentil nme-bsed HIV infection reporting Tble 6. Estimted numbers of AIDS cses in dult nd dolescent Hispnics, by trnsmission ctegory nd plce of birth, 2004 United Sttes Section 2 Deths Tble 7. Estimted numbers of deths of persons with AIDS, by yer of deth nd selected chrcteristics, United Sttes Section 3 Persons living with HIV/AIDS, AIDS, or HIV infection Tble 8. Estimted numbers of persons living with HIV/AIDS, by yer nd selected chrcteristics, res with confidentil nme-bsed HIV infection reporting Tble 9. Estimted numbers of persons living with HIV/AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory 35 res with confidentil nme-bsed HIV infection reporting Mp 1. Estimted rtes for dults nd dolescents living with HIV infection (not AIDS) or with AIDS (per 100,000 popultion), 2004 United Sttes Mp 2. Estimted rtes for children <13 yers of ge living with HIV infection (not AIDS) or with AIDS (per 100,000 popultion), 2004 United Sttes Tble 10. Estimted numbers of persons living with AIDS, by yer nd selected chrcteristics, United Sttes Tble 11. Estimted numbers of persons living with AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory United Sttes Tble 12. Estimted numbers of persons living with HIV infection (not AIDS) or with AIDS t the end of 2004, by re of residence nd ge ctegory United Sttes Reports of cses of AIDS, HIV infection, nd HIV/AIDS 3

4 Section 4 Survivl fter AIDS dignosis Tble 13. Proportion of persons surviving for more thn 12, 24, nd 36 months fter n AIDS dignosis in 2000, by selected chrcteristics United Sttes Figure 2. Proportion of persons surviving, by months fter AIDS dignosis during nd by yer of dignosis United Sttes Figure 3. Proportion of persons surviving, by months fter AIDS dignosis during nd by ge group United Sttes Figure 4. Proportion of persons surviving, by months fter AIDS dignosis during nd by rce/ethnicity United Sttes Section 5 Reports of cses of AIDS, HIV infection, nd HIV/AIDS Tble 14. Reported AIDS cses nd nnul rtes (per 100,000 popultion), by re of residence nd ge ctegory, cumultive through 2004 United Sttes Tble 15. Reported AIDS cses nd nnul rtes (per 100,000 popultion), by metropolitn re of residence nd ge ctegory, cumultive through 2004 United Sttes Tble 16. Reported cses of HIV infection (not AIDS), by re of residence nd ge ctegory, cumultive through res with confidentil nme-bsed HIV infection reporting Tble 17. Reported AIDS cses, by ge ctegory, trnsmission ctegory, nd sex, cumultive through 2004 United Sttes Tble 18. Reported cses of HIV infection (not AIDS), by ge ctegory, trnsmission ctegory, nd sex, cumultive through res with confidentil nme-bsed HIV infection reporting Tble 19. Reported AIDS cses for mle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 United Sttes Tble 20. Reported cses of HIV infection (not AIDS) for mle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through res with confidentil nme-bsed HIV infection reporting Tble 21. Reported AIDS cses for femle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 United Sttes Tble 22. Reported cses of HIV infection (not AIDS) for femle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through res with confidentil nme-bsed HIV infection reporting Tble 23. Reported cses of HIV/AIDS in infnts born to HIV-infected mothers, by yer of report nd selected chrcteristics, sttes with confidentil nme-bsed HIV infection reporting Technicl Notes Web ddresses for stte HIV Infection nd AIDS Surveillnce Reports Reports of cses of AIDS, HIV infection, nd HIV/AIDS

5 Commentry To better monitor the ptterns of HIV dignoses, ll sttes hve implemented HIV surveillnce. This report presents estimted numbers of cses of HIV/ AIDS from the 35 res (33 sttes, Gum, nd the U.S. Virgin Islnds) with integrted HIV nd AIDS surveillnce since t lest Two of these res begn integrted surveillnce in 2000: Gum nd New York. New York is the stte with the highest reported percentge (18%) of cumultive ntionl AIDS cses, nd inclusion of their integrted dt resulted in lrge numeric increses in the estimted number of HIV/ AIDS cses compred to previous HIV/AIDS surveillnce reports. From 2001 through 2004, the totl number of new cses of HIV/AIDS in the 35 res decresed slightly; however, HIV/AIDS prevlence (i.e., the number of persons living with HIV/AIDS) incresed during this time: t the end of 2004, n estimted 462,792 persons in the 35 res were dignosed nd living with HIV/AIDS. According to the number of reported AIDS cses, these 35 res represent pproximtely 61% of the epidemic in the United Sttes. The mp on the cover depicts the estimted number of cses of HIV/AIDS in 2004, by re of residence t dignosis, for persons residing in the 33 sttes with integrted HIV nd AIDS surveillnce. Surveillnce dt on HIV infections provide more complete picture of the epidemic nd the need for prevention nd cre services thn does the picture provided by AIDS dt lone. However, the number of new HIV dignoses does not necessrily reflect trends in HIV incidence (i.e., new infections) becuse some newly dignosed persons were infected recently while others were infected some time in the pst. One method for estimting HIV incidence is to pply the serologic testing lgorithm for recent HIV seroconversion (STARHS) to the serum specimens from which new HIV dignoses were mde. A totl of 34 res re using this method to estimte popultion-bsed HIV incidence: 5 res were funded in FY 2002 to pilot this method, 19 res were funded in FY 2003, nother 9 res were funded in FY 2004 nd one dditionl re ws funded in FY The monitoring of HIV incidence will be criticl in evluting progress towrd CDC s HIV Prevention Strtegic Pln gol of reducing the number of new HIV infections in the United Sttes from 40,000 to 20,000 per yer, to llocte resources nd evlute prevention progrm effectiveness. In 2002, CDC initited the Interstte Dupliction Evlution Project (IDEP), forml evlution compring HIV/AIDS records in the ntionl dtbse cross sttes in order to identify potentil duplicte cses. Current IDEP de-dupliction efforts were completed in December 2004, nd pproximtely 40,000 HIV/AIDS cses were found to be duplictes (representing less thn 5% of lmost 1 million cses tht hve been reported to CDC over the course of the epidemic); these duplicte cses hve been removed from the ntionl surveillnce dtbse nd from individul stte surveillnce dtbses. As result of this correction there my be minor reductions in reported cses displyed in this surveillnce report compred to the previous HIV/ AIDS surveillnce report. The 2004 HIV/AIDS Surveillnce Report presents dt on cses of HIV/AIDS. For nlyses of HIV/AIDS dt, we used dt from 35 res (i.e., 33 sttes, Gum, nd the U.S. Virgin Islnds) with mture HIV reporting systems (i.e., HIV reporting t lest since 2000) to llow for stbiliztion of dt collection nd for djustment of the dt in order to monitor trends. Tbles 1, 2, 8, nd 9 summrize cses nd prevlence of HIV/AIDS. For nlyses of AIDS cses, we used dt from the 50 sttes, the District of Columbi, U.S. dependencies, possessions, nd ssocited ntions. This report is orgnized in 5 sections: (1) cses of HIV/AIDS nd AIDS, (2) deths of persons with AIDS, (3) persons living with HIV/AIDS, AIDS, or HIV infection (not AIDS), (4) length of survivl fter AIDS dignosis, nd (5) reports of cses of AIDS, HIV infection (not AIDS), nd HIV/AIDS. In Sections 1 3, we present point estimtes of cse counts tht hve been djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. CDC routinely djusts dt for the presenttion of trends in the epidemic. Dt to estimte the number of cses of HIV/AIDS or AIDS; the number of persons living with HIV/AIDS, AIDS, or HIV infection (not AIDS); nd the number of deths mong persons with AIDS hve been sttisticlly djusted to correct for delys in the reporting of cses nd deths. To ssess trends in cses, deths, or prevlence, it is preferble to use djusted dt, presented by yer of dignosis insted of yer of report, to eliminte rtifcts of reporting in the surveillnce system. Therefore, for trends, the Reports of cses of AIDS, HIV infection, nd HIV/AIDS 5

6 reder is encourged to use the tbles in Sections 1 3 tht present trends by yer of dignosis, yer of deth, or yer-end prevlence. Section 4 presents estimtes of survivl for persons whose AIDS dignosis ws mde during 2000 (Tble 13) nd for persons whose dignosis ws mde during (Figures 2 4). Proportions of persons who survived for vrious lengths of time fter dignosis re presented by yer of dignosis, ge group, rce/ ethnicity, nd HIV trnsmission ctegory. Finlly, Section 5 presents reports of cses of HIV infection (not AIDS) nd cses of AIDS reported through The res included in tbultions of reported cses of HIV infection (not AIDS) re bsed on the dte tht confidentil nme-bsed HIV infection reporting ws implemented. For Tbles 16, 18, 20, nd 22, we used dt from 42 res to describe reports of HIV infection. These dt hve not been djusted for delys in reporting nd re presented by yer of report to CDC. Tbles tht present cses by yer of report represent the most up-to-dte informtion reported to CDC; however, cses by yer of report do not represent incident cses, the most recent dignoses, trends, or deths. Highlights of Anlyses Cses of HIV/AIDS nd cses of AIDS Cses of HIV/AIDS The estimted number of HIV/AIDS cses in the 35 res with confidentil nme-bsed HIV infection reporting decresed yer to yer from 2001 through 2003 nd then incresed pproximtely 1% from the end of 2003 (38,188) through the end of 2004 (38,730). Age group: From 2001 through 2004, the estimted number of HIV/AIDS cses decresed mong children less thn 13 yers of ge nd in the following ge groups: 13 14, 30 34, 35 39, 40 44, nd The estimted number of HIV/AIDS cses remined stble in the ge group yers, nd incresed in the following ge groups: 15 19, 20 24, 50 54, 55 59, 60 64, nd 65 yers nd older. The lrgest number of HIV/AIDS cses occurred mong persons ge yers nd ccounted for 17% of ll HIV/ AIDS cses dignosed in Rce/ethnicity: From 2001 through 2004, the estimted number of HIV/AIDS cses incresed mong whites, Asins/Pcific Islnders, nd Americn Indins/Alsk Ntives, nd decresed mong blcks nd Hispnics. Blcks ccounted for 50% of ll HIV/AIDS cses dignosed in Sex: From 2001 through 2004, the estimted number of HIV/AIDS cses decresed pproximtely 2% mong mles nd 15% mong femles. In 2004, mles ccounted for 73% of ll HIV/AIDS cses mong dults nd dolescents. Trnsmission ctegory: From 2001 through 2004, the estimted number of HIV/AIDS cses incresed mong men who hve sex with men (MSM). The estimted number of HIV/AIDS cses decresed mong injection drug users (IDUs), MSM who were lso IDUs, heterosexul dults nd dolescents, nd mong children. MSM (47%) nd persons exposed through heterosexul contct (33%) ccounted for 80% of ll HIV/AIDS cses dignosed in Of ll HIV infections dignosed in 2003, 39% progressed to AIDS within 12 months fter HIV infection ws dignosed. AIDS ws dignosed within 12 months fter the dignosis of HIV infection for lrger proportion of persons ged 35 yers nd older, IDUs, nd persons exposed through heterosexul contct (Tble 2). Cses of AIDS During , decreses in nnul AIDS cses begn to level; however, fter 2001, the estimted number of AIDS cses incresed ech yer (Tble 3). In 2004, the estimted rte of AIDS cses in the United Sttes ws 14.1 per 100,000 popultion (Tble 5). Age group: From 2000 through 2004, the estimted number of AIDS cses decresed 61% mong children less thn 13 yers of ge, 11% in the ge group 30 34, nd 10% in the ge group yers, nd remined stble in the ge group yers (Tble 3). The estimted number of AIDS cses incresed in the following ge groups: 15 19, 20 24, 25 29, 40 44, 45 49, 50 54, 55 59, 60 64, nd 65 yers nd older. The lrgest number of AIDS cses occurred mong persons ge yers nd ccounted for 21% of ll AIDS cses dignosed in Rce/ethnicity: From 2000 through 2004, the estimted number of AIDS cses incresed mong ll rcil nd ethnic groups (Tble 3). In 2004, rtes of AIDS cses were 56.4 per 100,000 in the blck popultion, 18.6 per 100,000 in the 6 Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS

7 Hispnic popultion, 7.9 per 100,000 in the Americn Indin/Alsk Ntive popultion, 6.0 per 100,000 in the white popultion, nd 3.7 per 100,000 in the Asin/Pcific Islnder popultion (Tble 5). Sex: From 2000 through 2004, the estimted number of AIDS cses incresed 10% mong femles nd 7% mong mles. Mles ccounted for 73% of ll AIDS cses dignosed in 2004 mong dults nd dolescents in the United Sttes (Tble 3). Rtes of AIDS cses in 2004 were 25.6 per 100,000 mong mles nd 9.0 per 100,000 mong femles (Tble 5). Trnsmission ctegory: From 2000 through 2004, the estimted number of AIDS cses decresed mong IDUs nd mong MSM who were lso IDUs (Tble 3). From 2000 through 2004, the estimted number of AIDS cses incresed mong MSM. Among persons exposed through heterosexul contct, the estimted number of AIDS cses incresed ech yer from 2000 through Region: From 2000 through 2004, the estimted number of AIDS cses incresed 25% in the South nd 13% in the Midwest, nd decresed 8% in the Northest, 6% in the West, nd 15% in the U.S. dependencies, possessions, nd ssocited ntions. Deths The estimted number of deths mong persons with AIDS decresed 8% from 2000 through 2004 (Tble 7). Age group: From 2000 through 2004, the estimted number of deths decresed mong children less thn 13 yers of ge nd in the following ge groups: 15 19, 25 29, 30 34, 35 39, 40 44, nd The estimted number of deths incresed in the ge groups 13 14, 20 24, 50 54, 55 59, 60 64, nd 65 yers nd older. Rce/ethnicity: From 2000 through 2004, the estimted number of deths mong persons with AIDS decresed mong whites, blcks, nd Asins/Pcific Islnders nd incresed mong Hispnics nd Americn Indins/Alsk Ntives. Sex nd trnsmission ctegory: From 2000 through 2004, mong mles, the estimted number of deths of MSM nd IDUs decresed. Among femles, the estimted number of deths of IDUs decresed. The estimted number of deths incresed from 2000 through 2004 mong dults nd dolescents of both sexes exposed through heterosexul contct. Region: The estimted number of deths in 2004 compred with 2003 decresed in the Northest nd the Midwest; remined stble in the West nd incresed in the South, nd U.S. dependencies, possessions, nd ssocited ntions. Persons living with HIV/AIDS, HIV infection (not AIDS), or AIDS Persons living with HIV/AIDS The estimted number of persons living with HIV/AIDS hs incresed stedily in the 35 res with confidentil nme-bsed HIV infection reporting (Tble 8). At the end of 2004, n estimted 462,792 persons were living with HIV/AIDS in the 35 res with confidentil nme-bsed HIV infection reporting since 2000: By ge group, the most cses (22%) were in the ge group yers. By rce/ethnicity, 48% were blck, 34% white, 17% Hispnic, nd less thn 1% ech were Americn Indin/Alsk Ntive nd Asin/ Pcific Islnder. By sex, 73% of dults nd dolescents living with HIV/AIDS were mle. Of the estimted 332,578 mle dults nd dolescents living with HIV/AIDS, 60% were MSM, 19% were IDUs, 13% hd been exposed through heterosexul contct, nd 7% were MSM who lso were IDUs. Of the estimted 123,405 femle dults nd dolescents living with HIV/ AIDS, 71% hd been exposed through heterosexul contct, nd 27% hd been exposed through injection drug use. Of the estimted 6,804 children living with HIV/AIDS, 90% hd been exposed perintlly. Prevlence rtes of HIV infection (not AIDS) In the 35 res with confidentil nme-bsed HIV infection reporting, the prevlence rte of HIV infection (not AIDS) mong dults nd dolescents ws estimted t per 100,000 t the end of 2004 (Mp 1). The rte for dults nd dolescents living with HIV infection (not AIDS) rnged from n estimted 15.0 per 100,000 (North Dkot) to n estimted per 100,000 (U.S. Virgin Islnds). The prevlence rte of HIV infection (not AIDS) mong children residing in the 35 res ws n estimted 7.9 per 100,000 t the end of 2004 (Mp 2). Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS 7

8 The rte for children living with HIV infection (not AIDS) rnged from n estimted zero per 100,000 in New Mexico, North Dkot, nd Gum, to n estimted 32.3 per 100,000 in New York. Persons living with AIDS AIDS prevlence hs lso incresed stedily since 2000 (Tble 10). At the end of 2004, n estimted 415,193 persons in the United Sttes were living with AIDS: By ge group, the most cses (23%) were in the ge group yers. By rce/ethnicity, 43% were blck, 35% white, 20% Hispnic, 1% Asin/Pcific Islnder nd less thn 1% Americn Indin/Alsk Ntive. By sex, 77% of dults nd dolescents living with AIDS were mle. By region, 39% resided in the South, 29% in the Northest, 19% in the West, 10% in the Midwest, nd 3% in the U.S. dependencies, possessions, nd ssocited ntions. Of the estimted 317,698 mle dults nd dolescents living with AIDS, 58% were MSM, 21% were IDUs, 11% hd been exposed through heterosexul contct, nd 8% were MSM who were lso IDUs. Of the estimted 93,566 femle dults nd dolescents living with AIDS, 64% hd been exposed through heterosexul contct, nd 34% hd been exposed through injection drug use. AIDS prevlence rtes In the United Sttes, the prevlence rte of AIDS mong dults nd dolescents ws estimted t per 100,000 t the end of 2004 (Mp 1). The rte for dults nd dolescents living with AIDS rnged from n estimted 4 per 100,000 (U.S. Pcific Islnds) to n estimted 1,906 per 100,000 (District of Columbi). The prevlence rte of AIDS mong children in the United Sttes ws estimted t 3.2 per 100,000 t the end of 2004 (Mp 2). The rte for children living with AIDS rnged from n estimted zero per 100,000 in Gum, Idho, Montn, Uth, nd the U.S. Pcific Islnds to n estimted 52.8 per 100,000 in the District of Columbi. Survivl fter AIDS dignosis Tble 13 is limited to dt on AIDS cses dignosed in 2000 in order to describe the survivl of persons whose dignosis ws mde reltively recently, but fr enough in the pst to permit meningful mesure of survivl. Figures 2, 3, nd 4 illustrte the proportion of surviving persons mong persons whose dignoses were mde over longer period, 1996 through Survivl (the estimted proportion of persons surviving given length of time fter dignosis) incresed with the yer of dignosis for dignoses mde during Yer-to-yer differences were smll during (Figure 2). Survivl decresed s ge t dignosis incresed mong persons t lest 35 yers old t dignosis nd in comprison with persons younger thn 35. Survivl ws similr for the ge groups nd Survivl ws gretest mong children less thn 13 yers of ge t dignosis (Figure 3). Survivl ws gretest mong MSM nd mong children with perintlly cquired HIV infection (Tble 13). Survivl ws intermedite mong men nd women who hd heterosexul contct with someone known to be HIV infected or t high risk for HIV infection, s well s mong MSM who lso were IDUs. Survivl ws lowest mong men nd women who were IDUs. Survivl, prticulrly t more thn 48 months fter dignosis, ws greter mong Asins/ Pcific Islnders, whites, nd Hispnics, thn mong blcks (Figure 4). Results were unstble or inconsistent for Americn Indins/Alsk Ntives becuse the numbers of persons in this rcil/ethnic ctegory were smll. Reports of Cses of AIDS, HIV infection (not AIDS), nd HIV/AIDS Tbles describe reports of cses of AIDS, HIV infection (not AIDS), nd of HIV/AIDS. Tbles 16, 18, 20, nd 22 re bsed on reports of cses of HIV infection (not AIDS) through 2004 from the 42 res tht hd implemented nme-bsed HIV infection reporting. Note tht not ll cses of HIV infection (not AIDS) or AIDS reported in 2004 reflected new dignoses; rther, the reported cses include cses dignosed during erlier yers. Reports of cses of HIV infection (not AIDS) Through 2004, totl of 229,411 persons were reported s hving HIV infection (not AIDS) in the 42 res with confidentil nme-bsed HIV infection reporting (Tble 16). Five sttes (New York, Florid, 8 Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS

9 Texs, New Jersey, nd North Crolin) reported 121,787 (53%) of the 229,411 cumultive cses of HIV infection (not AIDS) reported to CDC. In 2004, 3 sttes (New York, Florid, nd Texs) reported 15,283 (46%) of the 33,563 cses of HIV infection (not AIDS). By sex, in 2004, 70% of the 33,132 reported cses of HIV infection (not AIDS) mong dults nd dolescents were in mles, nd 30% were in femles (Tble 18). In 2004, 431 cses of HIV infection (not AIDS) in children were reported. Reports of AIDS cses Through 2004, totl of 918,286 persons hd been reported s hving AIDS in the United Sttes, dependencies, possessions, nd ssocited ntions (Tble 14). Three sttes (Cliforni, Florid, nd New York) reported 43% of the cumultive AIDS cses, nd 41% of AIDS cses reported to CDC in In the United Sttes, the rte of reported AIDS cses in 2004 ws 15.0 per 100,000 popultion. The rte of reported AIDS cses rnged from zero per 100,000 (U.S. Pcific Islnds) to per 100,000 (District of Columbi). By sex, in 2004, mles ccounted for 73% nd femles for 27% of 44,615 reported AIDS cses mong dults nd dolescents (Tble 17). In 2004, 122 AIDS cses in children were reported. Additionl Resources The following were prepred by using HIV/AIDS surveillnce dt: Selected MMWR rticles t pubs/mmwr.htm Public-use slides t grphics.htm Other surveillnce reports t stts/hsrlink.htm Public-use version of the AIDS surveillnce dt set (AIDS Public Informtion Dt Set [APIDS]) t Suggested Redings CDC. Advncing HIV prevention: new strtegies for chnging epidemic United Sttes, MMWR 2003;52: CDC. Dignosis nd reporting of HIV nd AIDS in 25 sttes United Sttes, MMWR 2002;51: CDC. Guidelines for ntionl HIV cse surveillnce, including monitoring for HIV infection nd AIDS. MMWR 1999;48(No. RR-13):1-31. CDC. HIV Prevention Strtegic Pln Through Atlnt: U.S. Deprtment of Helth nd Humn Services, CDC; Avilble t CDC. Increses in HIV dignoses 29 sttes, MMWR 2003;52: CDC. Updte: the AIDS epidemic in the United Sttes, MMWR 2002;51: Jnssen RS, Stten GA, Strmer SL, et l. New testing strtegy to detect erly HIV-1 infection for use in incidence estimtes nd for clinicl nd prevention purposes. JAMA 1998;280: Kron JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United Sttes t the turn of the century: n epidemic in trnsition. Am J Public Helth 2001;91: Nkshim AK, Fleming PL. HIV/AIDS surveillnce in the United Sttes, J Acquir Immune Defic Syndr 2003;32: CDC. Dignoses of HIV/AIDS 32 sttes, MMWR 2004;53: Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS 9

10 Tble 1. Estimted numbers of cses of HIV/AIDS, by yer of dignosis nd selected chrcteristics of persons, res with confidentil nme-bsed HIV infection reporting Yer of dignosis Age t dignosis (yrs) < ,012 1,023 1,027 1, ,241 3,154 3,345 3, ,608 4,499 4,290 4, ,776 6,305 5,688 5, ,261 7,719 7,112 6, ,699 6,395 6,483 6, ,709 4,486 4,514 4, ,735 2,643 2,733 2, ,411 1,330 1,414 1, Rce/ethnicity White, not Hispnic 11,242 11,352 11,097 11,806 Blck, not Hispnic 21,556 20,237 19,310 19,206 Hispnic 7,714 6,964 7,078 6,970 Asin/Pcific Islnder Americn Indin/Alsk Ntive Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 16,625 16,852 16,804 18,203 Injection drug use 5,171 4,379 4,177 3,828 Mle-to-mle sexul contct nd injection drug use 1,525 1,431 1,398 1,372 Heterosexul contct 5,095 4,843 4,720 4,581 Other Subtotl 28,630 27,689 27,279 28,143 Femle dult or dolescent Injection drug use 2,877 2,408 2,252 2,134 Heterosexul contct 9,192 8,709 8,248 8,102 Other Subtotl 12,280 11,303 10,706 10,410 Child (<13 yrs t dignosis) Perintl Other b Subtotl Subtotl for 33 sttes with confidentil nme-bsed HIV infection reporting 41,207 39,222 38,139 38,685 Subtotl for U.S. dependencies, possessions, nd ssocited ntions with confidentil nme-bsed HIV infection reporting Totl c 41,270 39,280 38,188 38,730 Cumultive Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. b Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. c Includes persons of unknown rce or multiple rces nd persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 10 Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDSnd HIV/AIDS

11 Tble 2. Estimted distribution of persons with nd persons without dignosis of AIDS within 12 months of dignosis of HIV infection, by selected chrcteristics, res with confidentil nme-bsed HIV infection reporting AIDS dignoses 12 Months <12 Months fter dignosis fter dignosis of HIV infection of HIV infection Totl No. (%) No. (%) No. (%) Age t dignosis (yrs) < , , , , , , , , , , , , , , , , , , , , , , Rce/ethnicity White, not Hispnic 6, , , Blck, not Hispnic 11, , , Hispnic 4, , , Asin/Pcific Islnder Americn Indin/Alsk Ntive Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 10, , , Injection drug use 2, , , Mle-to-mle sexul contct nd injection drug use , Heterosexul contct 2, , , Other b Subtotl 16, , , Femle dult or dolescent Injection drug use 1, , Heterosexul contct 5, , , Other b Subtotl 6, , , Child (<13 yrs t dignosis) Perintl Other c Subtotl Totl d 23, , , Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons in whom AIDS hs developed nd persons whose first dignosis of HIV infection nd the dignosis of AIDS were mde t the sme time. Dt exclude 46 persons whose month of dignosis of HIV infection is unknown. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Percentges represent proportions of the totl number of dignoses of HIV/AIDS mde during 2003 for the corresponding group (see row entries). Becuse row totls were clculted independently of the vlues for the subpopultions, the vlues in ech row my not sum to the row totl. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes 149 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDS nd HIV/AIDS 11

12 Tble 3. Estimted numbers of AIDS cses, by yer of dignosis nd selected chrcteristics of persons, United Sttes Yer of dignosis Cumultive through 2004 Age t dignosis (yrs) < , , ,329 1,343 1,467 1,664 1,788 34, ,432 3,239 3,279 3,276 3, , ,497 6,258 6,010 6,003 5, , ,930 8,649 8,716 8,763 8, , ,530 7,502 7,825 8,291 8, , ,200 5,401 5,656 6,102 6,245 99, ,007 3,199 3,436 3,672 3,932 54, ,528 1,567 1,718 1,854 2,079 29, , ,410 Rce/ethnicity White, not Hispnic 11,378 11,052 11,604 11,657 12, ,155 Blck, not Hispnic 19,510 19,473 19,934 20,685 20, ,278 Hispnic 7,957 7,974 7,907 8,632 8, ,164 Asin/Pcific Islnder ,317 Americn Indin/Alsk Ntive ,084 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 15,374 15,510 16,442 17,139 17, ,380 Injection drug use 7,036 6,447 6,247 6,213 5, ,162 Mle-to-mle sexul contct nd injection drug use 2,102 2,056 1,982 1,996 1,920 64,833 Heterosexul contct 4,162 4,440 4,771 4,967 5,149 59,939 Other b ,085 Subtotl 28,974 28,743 29,730 30,578 31, ,399 Femle dult or dolescent Injection drug use 3,393 3,175 3,008 3,068 3,184 72,651 Heterosexul contct 6,785 6,930 7,181 7,859 7,979 99,175 Other b ,636 Subtotl 10,415 10,348 10,429 11,184 11, ,463 Child (<13 yrs t dignosis) Perintl ,779 Other c Subtotl ,443 Region of residence Northest 12,105 11,212 10,395 11,149 11, ,792 Midwest 3,968 3,949 4,303 4,495 4,498 93,701 South 15,841 16,598 17,751 18,612 19, ,449 West 6,443 6,258 6,745 6,474 6, ,730 U.S. dependencies, possessions, nd ssocited ntions 1,156 1,190 1,073 1, ,634 Totl d 39,513 39,206 40,267 41,831 42, ,306 39,513 39,206 40,267 41,831 42, ,306 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes persons with dignosis of AIDS from the beginning of the epidemic through b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes persons of unknown rce or multiple rces nd persons of unknown sex. Cumultive totl includes 2,308 persons of unknown rce or multiple rces nd 2 persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 12 Reports of Cses cses of HIV/AIDS AIDS, nd infection, AIDS nd HIV/AIDS

13 Tble 4. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis nd trnsmission ctegory, United Sttes Yer of dignosis Cumultive through 2004 Rce/ethnicity White, not Hispnic ,612 Blck, not Hispnic ,590 Hispnic ,128 Asin/Pcific Islnder Americn Indin/Alsk Ntive Trnsmission ctegory Hemophili/cogultion disorder Mother with the following risk fctor for, or documented, HIV infection ,779 Injection drug use ,338 Sex with injection drug user ,524 Sex with bisexul mle Sex with person with hemophili Sex with HIV-infected trnsfusion recipient Sex with HIV-infected person, risk fctor not specified ,515 Receipt of blood trnsfusion, blood components, or tissue Hs HIV infection, risk fctor not specified ,984 Receipt of blood trnsfusion, blood components, or tissue Other/risk fctor not reported or identified Totl b ,443 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes children with dignosis of AIDS, from the beginning of the epidemic through b Includes children of unknown rce or multiple rces. Cumultive totl includes 24 children of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Figure 1. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis, United Sttes Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDS nd HIV/AIDS 13

14 Tble 5. Estimted numbers of cses nd rtes (per 100,000 popultion) of AIDS, by rce/ethnicity, ge ctegory, nd sex, sttes nd the District of Columbi Adults or dolescents Mles Femles Totl Children (<13 yrs) Totl Rce/ethnicity No. Rte No. Rte No. Rte No. Rte No. Rte White, not Hispnic 10, , , , Blck, not Hispnic 13, , , , Hispnic 6, , , , Asin/Pcific Islnder Americn Indin/Alsk Ntive Totl 30, , , , Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Dt exclude cses from the U.S. dependencies, possessions, nd ssocited ntions, s well s cses in persons whose stte or re of residence is unknown, becuse of the lck of census informtion by rce nd ge ctegories for these res. Includes persons of unknown rce or multiple rces. Totl includes 183 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Tble 5b. Estimted numbers of cses nd rtes (per 100,000 popultion) of HIV/AIDS, by rce/ethnicity, ge ctegory, nd sex, sttes with confidentil nme-bsed HIV infection reporting Adults or dolescents Mles Femles Totl Children (<13 yrs) Totl Rce/ethnicity No. Rte No. Rte No. Rte No. Rte No. Rte White, not Hispnic 10, , , , Blck, not Hispnic 12, , , , Hispnic 5, , , , Asin/Pcific Islnder Americn Indin/Alsk Ntive Totl b 28, , , , Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 33 sttes hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, nd Wyoming. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Becuse row totls were clculted independently of vlues for the subpopultions, the vlue in ech row my not sum to the row totl. b Includes persons of unknown rce or multiple rces. Totl includes 146 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 14 Reports of Cses cses of HIV/AIDS AIDS, nd infection, AIDS nd HIV/AIDS

15 Tble 6. Estimted numbers of AIDS cses in dult nd dolescent Hispnics, by trnsmission ctegory nd plce of birth, 2004 United Sttes Plce of birth Centrl/South United Sttes Americ Cub Mexico Puerto Rico Totl Trnsmission ctegory No. % No. % No. % No. % No. % No. % Mle-to-mle sexul contct 1, , Injection drug use , Mle-to-mle sexul contct nd injection drug use Heterosexul contct , Other b Totl c 2, , , , Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes 269 persons whose plce of birth is not mong those listed nd 1,548 persons whose plce of birth is unknown. Becuse row totls were clculted independently of the vlues for the subpopultions, the vlues in ech row my not sum to the row totl. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports of cses Cses of AIDS, of HIV/AIDS infection, nd AIDS nd HIV/AIDS 15

16 Tble 7. Estimted numbers of deths of persons with AIDS, by yer of deth nd selected chrcteristics, United Sttes Yer of deth Cumultive through 2004 Age t deth (yrs) < , , , , ,993 1,744 1,555 1,373 1,157 96, ,346 3,292 3,108 2,969 2, , ,523 3,835 3,726 3,800 3, , ,081 3,121 3,364 3,432 3,016 67, ,966 2,152 2,396 2,524 2,314 39, ,007 1,141 1,228 1,403 1,343 22, , ,004 Rce/ethnicity White, not Hispnic 5,325 5,194 5,210 5,091 4, ,220 Blck, not Hispnic 8,605 9,011 8,974 8,950 7, ,045 Hispnic 3,025 3,195 3,117 3,537 3,228 93,163 Asin/Pcific Islnder ,272 Americn Indin/Alsk Ntive ,578 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 5,955 6,068 6,016 5,990 5, ,053 Injection drug use 4,070 4,074 4,062 4,116 3, ,070 Mle-to-mle sexul contct nd injection drug use 1,324 1,366 1,323 1,322 1,180 39,467 Heterosexul contct 1,389 1,528 1,513 1,634 1,548 24,268 Other b ,843 Subtotl 12,933 13,202 13,080 13,222 11, ,701 Femle dult or dolescent Injection drug use 1,892 1,907 1,977 1,989 1,744 41,178 Heterosexul contct 2,150 2,342 2,331 2,470 2,327 39,576 Other b ,142 Subtotl 4,129 4,340 4,400 4,560 4,138 84,897 Child (<13 yrs t dignosis) Perintl ,982 Other c Subtotl ,515 Region of residence Northest 5,200 5,130 5,213 5,654 4, ,693 Midwest 1,622 1,646 1,623 1,199 1,234 50,333 South 7,078 7,386 7,361 7,839 7, ,690 West 2,567 2,683 2,585 2,428 2, ,183 U.S. dependencies, possessions, nd ssocited ntions ,214 Totl d 17,139 17,611 17,544 17,849 15, ,113 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes persons who died with AIDS, from the beginning of the epidemic through b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes persons of unknown rce or multiple rces nd persons of unknown sex. Cumultive totl includes 836 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 16 Reports of cses of AIDS, Deths HIV infection, nd HIV/AIDS

17 Tble 8. Estimted numbers of persons living with HIV/AIDS, by yer nd selected chrcteristics, res with confidentil nme-bsed HIV infection reporting Age s of end of yer (yrs) <13 4,838 4,598 4,187 3, ,123 1, ,745 2,968 3,301 3, ,500 12,033 12,582 13, ,334 25,768 26,538 27, ,672 51,896 50,416 49, ,539 83,133 81,891 80, ,325 86,422 93,414 99, ,008 65,879 72,498 79, ,929 40,488 45,932 52, ,271 19,550 23,286 27, ,781 9,497 11,098 13, ,674 7,816 9,099 10,861 Rce/ethnicity White, not Hispnic 133, , , ,172 Blck, not Hispnic 181, , , ,028 Hispnic 63,105 68,252 72,967 78,039 Asin/Pcific Islnder 1,796 2,084 2,415 2,765 Americn Indin/Alsk Ntive 1,587 1,728 1,865 1,996 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 159, , , ,085 Injection drug use 57,287 58,959 60,113 61,799 Mle-to-mle sexul contct nd injection drug use 21,643 22,201 22,688 23,337 Heterosexul contct 34,386 37,986 41,291 44,655 Other 3,445 3,524 3,602 3,702 Subtotl 276, , , ,578 Femle dult or dolescent Injection drug use 30,977 32,003 32,742 33,621 Heterosexul contct 68,173 74,925 81,007 87,262 Other 2,077 2,236 2,383 2,523 Subtotl 101, , , ,405 Child (<13 yrs t dignosis) Perintl 5,810 5,954 6,057 6,100 Other b Subtotl 6,515 6,657 6,755 6,804 Totl c 384, , , ,792,,,, Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. b Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. c Includes persons of unknown rce or multiple rces nd persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports Persons of living cses with of HIV/AIDS, infection, AIDS, or nd HIV HIV/AIDS infection 17

18 Tble 9. Estimted numbers of persons living with HIV/AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory 35 res with confidentil nme-bsed HIV infection reporting Americn White, not Blck, not Asin/Pcific Indin/Alsk Hispnic Hispnic Hispnic Islnder Ntive Totl Trnsmission ctegory No. % No. % No. % No. % No. % No. % Mle dult or dolescent Mle-to-mle sexul contct 101, , , , , Injection drug use 12, , , , Mle-to-mle sexul contct nd injection drug use 10, , , ,337 7 Heterosexul contct 6, , , , Other b 1, , ,702 1 Subtotl 132, , , , , , Femle dult or dolescent Injection drug use 8, , , , Heterosexul contct 15, , , , Other b , ,523 2 Subtotl 23, , , , Child (<13 yrs t dignosis) Perintl , , , Other c Subtotl , , , Totl d 157, ,028 78,039 2,765 1, ,792 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes 2,793 persons of unknown rce or multiple rces. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes 5 persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 18 Persons Reports living of cses with of HIV/AIDS, AIDS, infection, or HIV nd infection HIV/AIDS

19 Reports Persons of living cses with of HIV/AIDS, infection, AIDS, or nd HIV HIV/AIDS infection 19

HIV Surveillance in Women. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

HIV Surveillance in Women. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Surveillnce in Women Ntionl Center for HIV/AIDS, Virl Heptitis, STD & TB Prevention Division of HIV/AIDS Prevention Dignoses of HIV Infection mong Adult nd Adolescent Femles, by Rce/Ethnicity, 2006

More information

Community. Profile Yellowstone County. Public Health and Safety Division

Community. Profile Yellowstone County. Public Health and Safety Division Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl

More information

Community. Profile Lewis & Clark County. Public Health and Safety Division

Community. Profile Lewis & Clark County. Public Health and Safety Division Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl

More information

Community. Profile Missoula County. Public Health and Safety Division

Community. Profile Missoula County. Public Health and Safety Division Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk

More information

Community. Profile Big Horn County. Public Health and Safety Division

Community. Profile Big Horn County. Public Health and Safety Division Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl

More information

Community. Profile Powell County. Public Health and Safety Division

Community. Profile Powell County. Public Health and Safety Division Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk

More information

Community. Profile Anaconda- Deer Lodge County. Public Health and Safety Division

Community. Profile Anaconda- Deer Lodge County. Public Health and Safety Division Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12

More information

Breast Cancer Statistics, 2013

Breast Cancer Statistics, 2013 Brest Cncer Sttistics, 2013 Crol DeSntis, MPH 1 *; Jiemin M, PhD 1 ; Leh Bryn, MPH 1 ; Ahmedin Jeml, DVM, PhD 2 In this rticle, the Americn Cncer Society provides n overview of femle brest cncer sttistics

More information

Community. Profile Carter County. Public Health and Safety Division

Community. Profile Carter County. Public Health and Safety Division Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk

More information

Invasive Pneumococcal Disease Quarterly Report. July September 2017

Invasive Pneumococcal Disease Quarterly Report. July September 2017 Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report

More information

Epidemiology of the Viral Hepatitis-HIV Syndemic in San Francisco: A Collaborative Surveillance Approach

Epidemiology of the Viral Hepatitis-HIV Syndemic in San Francisco: A Collaborative Surveillance Approach Dt Hrmoniztion nd Registry Mtching Epidemiology of the Virl Heptitis-HIV Syndemic in Sn Frncisco: A Collbortive Surveillnce Approch Meliss A. Snchez, PhD, MA Susn Scheer, PhD, MPH b Sue Shllow, MPH, CACLS

More information

XII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV

XII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies

More information

Appendix J Environmental Justice Populations

Appendix J Environmental Justice Populations Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:

More information

Urinary Tract Infection in Men

Urinary Tract Infection in Men C H A P T E R 1 9 Urinry Trct Infection in Men Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................623

More information

A Two-Stage Sampling Method for Clinical Surveillance of Individuals in Care for HIV Infection in the United States

A Two-Stage Sampling Method for Clinical Surveillance of Individuals in Care for HIV Infection in the United States Reserch Articles A Two-Stge Smpling Method for Clinicl Surveillnce of Individuls in Cre for HIV Infection in the United Sttes Ptrick S. Sullivn, DVM, PhD John M. Kron, PhD Fye E. Mlitz, MPH b Stephnie

More information

Estimating the Cost to U.S. Health Departments to Conduct HIV Surveillance

Estimating the Cost to U.S. Health Departments to Conduct HIV Surveillance Reserch Articles Estimting the Cost to U.S. Helth Deprtments to Conduct HIV Surveillnce Rm K. Shresth, PhD Stephnie L. Snsom, PhD, MPP, MPH Benjmin T. Lffoon, BS Pul G. Frnhm, PhD R. Luke Shouse, MD Kren

More information

Invasive Pneumococcal Disease Quarterly Report July September 2018

Invasive Pneumococcal Disease Quarterly Report July September 2018 Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.

More information

msmr MEDICAL SURVEILLANCE MONTHLY REPORT INSIDE THIS ISSUE: A publication of the Armed Forces Health Surveillance Center Summary tables and figures

msmr MEDICAL SURVEILLANCE MONTHLY REPORT INSIDE THIS ISSUE: A publication of the Armed Forces Health Surveillance Center Summary tables and figures VOL. 17 NO. 09 SEPTEMBER 2010 msmr A publiction of the Armed Forces Helth Surveillnce Center MEDICAL SURVEILLANCE MONTHLY REPORT Source: CDC INSIDE THIS ISSUE: Contct trnsfer of vccini virus from U.S.

More information

Ethnic Disparities in Stroke Recognition in Individuals with Prior Stroke

Ethnic Disparities in Stroke Recognition in Individuals with Prior Stroke Reserch Articles Ethnic Disprities in Stroke Recognition in Individuls with Prior Stroke Chrles Ellis, PhD Leonrd E. Egede, MD, MS,c SYNOPSIS Ojective. Studies of stroke wreness suggest tht knowledge of

More information

Potassium Intake of the U.S. Population

Potassium Intake of the U.S. Population Food Surveys Reserch Group Dietry Dt Brief No. 10 September 2012 Highlights The verge potssium intke of the U.S. popultion 2 yers nd older ws 2640 mg per dy nd intke of the U.S. popultion hs remined reltively

More information

Trends in Mortality From COPD Among Adults in the United States

Trends in Mortality From COPD Among Adults in the United States [ Originl Reserch COPD ] Trends in Mortlity From COPD Among Adults in the United Sttes Erl S. Ford, MD, MPH BACKGROUND: COPD imposes lrge public helth burden interntionlly nd in the United Sttes. The objective

More information

Urinary Tract Infection in Women

Urinary Tract Infection in Women C H A P T E R 1 8 Urinry Trct Infection in Women Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................589

More information

Metabolic syndrome (MetS) is defined by a group

Metabolic syndrome (MetS) is defined by a group ORIGINAL ARTICLE Prevlence of Metolic Syndrome in Lrge Integrted Helth Cre System in North Crolin Rohn Mhleshwrkr, Yhenneko J. Tylor, Melnie D. Spencer, Svet Mohnn ckground Metolic syndrome (MetS) is cluster

More information

Supplementary Online Content

Supplementary Online Content Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern

More information

Cost-Effectiveness of Finding New HIV Diagnoses Using Rapid HIV Testing in Community-Based Organizations

Cost-Effectiveness of Finding New HIV Diagnoses Using Rapid HIV Testing in Community-Based Organizations Reserch Articles Cost-Effectiveness of Finding New HIV Dignoses Using Rpid HIV Testing in Community-Bsed Orgniztions Rm K. Shresth, PhD Hollie A. Clrk, MPH Stephnie L. Snsom, PhD, MPP, MPH Binwei Song,

More information

Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria

Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion

More information

Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites,

Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, Reserch Results of Heptitis C Birth-Cohort Testing nd Linkge to Cre in Selected U.S. Sites, 2012 2014 Rjiv C. Ptel, MPH Cludi Vellozzi, MD, MPH Bryce D. Smith, PhD, MSSW,c ABSTRACT Ojective. Following

More information

Between 45% and 85% of the approximately 4 million people

Between 45% and 85% of the approximately 4 million people CLINICAL Incresing Heptitis C Screening in Lrge Integrted Helth System: Science nd Policy in Concert Crl V. Rodriguez, PhD; Kevin B. Rubenstein, MS; Benjmin Lins, MD; Hihong Hu, MS; nd Michel Horberg,

More information

PNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :

PNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 : PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged

More information

Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain

Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr

More information

CheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer

CheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn

More information

3.3 Verotoxigenic E. coli

3.3 Verotoxigenic E. coli 3.3 Verotoxigenic E. coli Summry Number of VTEC cses, 215: 73 Crude incidence rte, 215: 15.9/1, Number of VTEC-ssocited HUS, 215: 22 Number of VTEC cses, 214: 77 Introduction For mny yers, Irelnd hs the

More information

The Centers for Disease

The Centers for Disease originlcontributions Evluting the HIV Continuum of Cre within Lrge Integrted Helth System by Michel J. Willims, PhrmD nd Thoms J. Dilworth, PhrmD Abstrct Objective: The primry study objective ws to describe

More information

EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1

EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were

More information

Area-Level Socioeconomic Disadvantage and Severe Pulmonary Tuberculosis: U.S.,

Area-Level Socioeconomic Disadvantage and Severe Pulmonary Tuberculosis: U.S., Reserch Articles Are-Level Socioeconomic Disdvntge nd Severe Pulmonry Tuberculosis: U.S., 2000 2008 Eyl Oren, PhD,b Mshiro Nrit, MD b,c Chrles ln, MD Jonthn Myer, PhD ABSTRACT Objectives. Lower socioeconomic

More information

Supplementary Online Content

Supplementary Online Content Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA

More information

Assessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II

Assessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)

More information

Anemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project

Anemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project Kidney Interntionl, Vol. 64 (2003), pp. 1120 1124 Anemi in peditric hemodilysis ptients: Results from the 2001 ESRD Clinicl Performnce Mesures Project DIANE L. FRANKENFIELD, ALICA M. NEU, BRADLEY A. WARADY,

More information

Rates of weight change for black and white Americans over a twenty year period

Rates of weight change for black and white Americans over a twenty year period Interntionl Journl of Obesity (2003) 27, 498 504 & 2003 Nture Publishing Group All rights reserved 0307-0565/03 $25.00 www.nture.com/ijo PAPER Rtes of weight chnge for blck nd white Americns over twenty

More information

Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study

Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study Syddnsk Universitet Recll Bis in Childhood Atopic Diseses Among Adults in The Odense Adolescence Cohort Study Mørtz, Chrlotte G; Andersen, Klus Ejner; Bindslev-Jensen, Crsten Published in: Act Dermto-Venereologic

More information

Relation of Tumor Size, Lymph Node Status, and Survival in

Relation of Tumor Size, Lymph Node Status, and Survival in Reltion of Tumor Size, Lymph Node Sttus, nd Survivl in 24,74 Brest Cncer Cses CHRISTINE L. CARTER, PHD, MPH,* CAROL ALLEN, PHD,t AND DONALD E. HENSON, MD* Two of the most importnt prognostic indictors

More information

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding

More information

Geographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria.

Geographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria. Journl of Applied Biosciences 27: 1736-1741 ISSN 1997 5902 Geogrphicl influence on digit rtio (2D:4D): cse study of Andoni nd Ikwerre ethnic groups in Niger delt, Nigeri. Gwunirem, Isrel U 1 nd Ihemelndu,

More information

University of Texas Health Science Center, San Antonio, San Antonio, Texas, USA

University of Texas Health Science Center, San Antonio, San Antonio, Texas, USA Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University

More information

Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008

Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008 Reserch rticles Differences in heptitis B infection rte between ethnic groups in ntentl women in Birminghm, United Kingdom, My 2004 to December 2008 M Cley (Michel.cley@wrwickshire.nhs.uk) 1, T Fowler

More information

Hepatitis A virus (HAV) infection contributes approximately

Hepatitis A virus (HAV) infection contributes approximately Multiple Fctors Contribute to Positive Results for Heptitis A Virus Immunoglobulin M Antibody Adnn Altoom, MD, PhD; M. Qsim Ansri, MD; Jennifer Cuthbert, MD Context. In the United Sttes, successful vccintion

More information

DXA: Can It Be Used as a Criterion Reference for Body Fat Measurements in Children?

DXA: Can It Be Used as a Criterion Reference for Body Fat Measurements in Children? nture publishing group rticles methods AND techniques DXA: Cn It Be Used s Criterion Reference for Body Ft Mesurements in Children? Romn J. Shypilo 1, Nncy F. Butte 1 nd Kenneth J. Ellis 1 Objective: Dul-energy

More information

Longitudinal Association of Maternal Attempt to Lose Weight During the Postpartum Period and Child Obesity at Age 3 Years

Longitudinal Association of Maternal Attempt to Lose Weight During the Postpartum Period and Child Obesity at Age 3 Years nture publishing group Longitudinl Assocition of Mternl Attempt to Lose Weight During the Postprtum Period nd Child Obesity t Age 3 Yers Kendrin R. Sonneville 1,2, Sheryl L. Rifs-Shimn 3, Emily Oken 3,

More information

A Four-System Comparison of Patients With Chronic Illness: The Military Health System, Veterans Health Administration, Medicaid, and Commercial Plans

A Four-System Comparison of Patients With Chronic Illness: The Military Health System, Veterans Health Administration, Medicaid, and Commercial Plans MILITARY MEDICINE, 174, 9:936, 2009 A Four-System Comprison of Ptients With Chronic Illness: The Militry Helth System, Veterns Helth Administrtion, Medicid, nd Commercil Plns Teres B. Gibson, PhD * ; Todd

More information

Clinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number

Clinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess

More information

Addendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)

Addendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years) Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments

More information

SYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT

SYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of

More information

Using Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids

Using Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress

More information

Not for Citation or Publication Without Consent of the Author

Not for Citation or Publication Without Consent of the Author Not for Cittion or Puliction Without Consent of the Author AN AUTOMATED SEX PHEROMONE TRAP FOR MONITORING ADULT CM AND OFM AND THE INFLUENCE OF TRAP COLOR ON MOTH AND NON-TARGET CAPTURES Brin L. Lehmn

More information

Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge and Risk Factors in Ethiopian Military Personnel

Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge and Risk Factors in Ethiopian Military Personnel MILITARY MEDICINE, 169, 3:221, 2004 Humn Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge nd Risk Fctors in Ethiopin Militry Personnel Gurntor: Ludmil N. Bkhirev, MD MPH Contributors:

More information

There has been little systematic

There has been little systematic doi: 10.1377/hlthff.2009.0666 HEALTH AFFAIRS 29, NO. 3 (2010): 398 404 2010 Project HOPE The People-to-People Helth Foundtion, Inc. By Crmen Pierns nd Brry M. Popkin Trends In Sncking Among U.S. Children

More information

Quantifying perceived impact of scientific publications

Quantifying perceived impact of scientific publications Quntifying perceived impct of scientific publictions Filippo Rdicchi, Alexnder Weissmn, nd John Bollen Center for Complex Networks nd Systems Reserch, School of Informtics nd Computing, Indin University,

More information

Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic

Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic nture publishing group rticles Will All s Become Overweight or Obese? Estimting the Progression nd Cost of the US Obesity Epidemic Youf Wng 1, My A. Beydoun 1, Ln Ling 2, Benjmin Cbllero 1 nd Shiriki K.

More information

Prostate cancer is among the most common malignancies

Prostate cancer is among the most common malignancies Implictions of Evolving Delivery System Reforms for Prostte Cncer Cre Brent K. Hollenbeck, MD, MS; Mggie J. Bierlein, MS; Smuel R. Kufmn, MS; Lindsey Herrel, MD; Ted A. Skolrus, MD, MPH; Dvid C. Miller,

More information

BMI and Mortality: Results From a National Longitudinal Study of Canadian Adults

BMI and Mortality: Results From a National Longitudinal Study of Canadian Adults nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross

More information

Effectiveness of Belt Positioning Booster Seats: An Updated Assessment

Effectiveness of Belt Positioning Booster Seats: An Updated Assessment ARTICLES Effectiveness of Belt Positioning Booster Sets: An Updted Assessment AUTHORS: Kristy B. Arbogst, PhD, Jessic S. Jermkin, DSc, Michel J. Klln, MS, b nd Dennis R. Durbin, MD, MSCE,b Center for Injury

More information

Diabetes affects 29 million Americans, imposing a substantial

Diabetes affects 29 million Americans, imposing a substantial CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.

More information

Potential for Interactions Between Dietary Supplements and Prescription Medications a

Potential for Interactions Between Dietary Supplements and Prescription Medications a CLINICAL RESEARCH STUDY Potentil for Interctions Between Dietry Supplements nd Prescription Medictions Amit Sood, MD, MSc, Rich Sood, MD, b Frncis J. Brinker, ND, Rvneet Mnn, MBBS, c Lur L. Loehrer, Dietlind

More information

Effects of age, density, and seasonality on molt pattern in the mammal genus (Peromyscus)

Effects of age, density, and seasonality on molt pattern in the mammal genus (Peromyscus) University of New Hmpshire University of New Hmpshire Scholrs' Repository Honors Theses nd Cpstones Student Scholrship Spring 2015 Effects of ge, density, nd sesonlity on molt pttern in the mmml genus

More information

The Quality and Outcomes Framework (QOF) is a pay-for-performance

The Quality and Outcomes Framework (QOF) is a pay-for-performance Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher

More information

HEMOGLOBIN STANDARDS*

HEMOGLOBIN STANDARDS* HEMOGLOBIN STANDARDS* RUSSELL L. HADEN Clevelnd Clinic, Clevelnd, Ohio Estimtions of hemoglobin often re unstisfctory to the lbortory worker nd the reports my be confusing to the clinicin. Unfortuntely,

More information

Seasonal influenza vaccination programme country profile: Ireland

Seasonal influenza vaccination programme country profile: Ireland Sesonl influenz vccintion progrmme country profile: Irelnd 2012 13 Seson Bckground informtion Influenz immunistion policy nd generl fcts bout Irelnd Volume indices of GDP per cpit in 2011 nd 2013 (EU-

More information

May 28, Congressional Requesters

May 28, Congressional Requesters United Sttes Government Accountbility Office Wshington, DC 20548 My 28, 2010 Congressionl Requesters Subject: Federl Funds: Fiscl Yers 2002-2009 Obligtions, Disbursements, nd Expenditures for Selected

More information

Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool. Rodolfo Valdez, Ph.D.

Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool. Rodolfo Valdez, Ph.D. Journl of Dietes Science nd Technology Volume 3, Issue 4, July 2009 Dietes Technology Society SYMPOSIUM Detecting Undignosed Type 2 Dietes: Fmily History s Risk Fctor nd Screening Tool Rodolfo, Ph.D. Astrct

More information

Metformin and breast cancer stage at diagnosis: a population-based study

Metformin and breast cancer stage at diagnosis: a population-based study ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe

More information

Opioid Use and Survival at the End of Life: A Survey of a Hospice Population

Opioid Use and Survival at the End of Life: A Survey of a Hospice Population 532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,

More information

Water fl uoridation and dental caries in 5- and 12-year-old children from Canterbury and Wellington

Water fl uoridation and dental caries in 5- and 12-year-old children from Canterbury and Wellington 18 10 NEW ZEALAND DENTAL JOURNAL MARCH 004 Wter fl uoridtion nd dentl cries in 5- nd 1-yer-old children from Cnterbury nd Wellington MARTIN LEE AND PETER J DENNISON New Zelnd Dentl Journl 100, No. 1: 10-15;

More information

Lifetime exercise activity and breast cancer risk among post-menopausal women

Lifetime exercise activity and breast cancer risk among post-menopausal women Article no. bjoc.1999.0610 Lifetime exercise ctivity nd brest cncer risk mong post-menopusl women CL Crpenter, RK Ross, A Pgnini-Hill nd L Bernstein Deprtment of Preventive Medicine, University of Southern

More information

Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort

Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort Specil Report Risk of Colorectl Cncer by Subsite in Swedish Prostte Cncer Cohort Yunxi Lu, MD, PhD, Rickrd Ljung, MD, PhD, Ann Mrtling, MD, PhD, nd Mts Lindbld, MD, PhD Bckground: The reltionship between

More information

Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians

Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians Kidney Interntionl, Vol. 35 (1989), pp. 681 687 Incidence of proteinuri in type 2 dibetes mellitus in the Pim Indins CHARLES L. KUNZELMAN,' WILLIAM C. KNOWLER, DAVID J. PETTITT, nd PETER H. BENNETT Dibetes

More information

key words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization

key words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,

More information

Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey

Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey L Biddle, D Gunnell, D Shrp nd J L Donovn Fctors influencing help seeking in mentlly distressed young dults: cross-sectionl survey Lucy Biddle, Dvid Gunnell, Debbie Shrp nd Jenny L Donovn SUMMARY Bckground:

More information

Epidemiological survey and analysis of asthma in children aged 0-14 years old in urban and rural areas of Chengdu region

Epidemiological survey and analysis of asthma in children aged 0-14 years old in urban and rural areas of Chengdu region Originl Article Epidemiologicl survey nd nlysis of sthm in children ged 0-14 yers old in urbn nd rurl res of Chengdu region Min Li 1, Qiong Zhng 2, Wei-Jun Shi 2, Ln Li 1, Yn Li 2, Ying Png 1, Bin Yo 1,

More information

Inadequate health literacy is a

Inadequate health literacy is a Testing the BRIEF Helth Litercy Screening Tool Jolie Hun, PhD, Virgini Nolnd-Dodd, PhD, MPH, Jill Vrnes, EdD, John Grhm-Pole, MD, Brbr Rienzo, PhD, nd Ptrici Donldson, RN Due to the oppressive strins lid

More information

Single-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA

Single-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA Single-Molecule Studies of Unlbelled Full-Length p53 Protein Binding to DNA Philipp Nuttll, 1 Kidn Lee, 2 Pietro Ciccrell, 3 Mrco Crminti, 3 Giorgio Ferrri, 3 Ki- Bum Kim, 2 Tim Albrecht 1* 1 Imperil College

More information

Colon Cancer Treatment: Are There Racial Disparities in an Equal-Access Healthcare System?

Colon Cancer Treatment: Are There Racial Disparities in an Equal-Access Healthcare System? ORIGINAL CONTRIBUTION Colon Cncer Tretment: Are There Rcil Disprities in n Equl-Access Helthcre System? Abegil A. Gill, M.P.H 1 Lindsey Enewold, Ph.D. 1 Sheli H. Zhm, Sc.D. 2 Crig D. Shriver, M.D. 3,4,5

More information

Soybean Hulls as an Alternative Feed for Horses

Soybean Hulls as an Alternative Feed for Horses Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore

More information

Reducing the Risk. Logic Model

Reducing the Risk. Logic Model Reducing the Risk Logic Model ETR (Eduction, Trining nd Reserch) is nonprofit orgniztion committed to providing science-bsed innovtive solutions in helth nd eduction designed to chieve trnsformtive chnge

More information

ECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND

ECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND ECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND CS Pndv 1, K Annd 1, Sngsom Sinwt 2 nd FU Ahmed 1 1 IDD Study Group, All Indi Institute of Medicl Sciences, New Delhi, Indi; 2 Division of Nutrition,

More information

Trends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?

Trends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion? ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public

More information

The Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes

The Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,

More information

Cost of Child Lead Poisoning to Taxpayers in Mahoning County, Ohio

Cost of Child Lead Poisoning to Taxpayers in Mahoning County, Ohio Specil Report on Led Poisoning in Children Cost of Child Led Poisoning to Txpyers in Mhoning County, Ohio Mtthew Stefnk, MPH,b Joe Diorio, MS Lrry Frisch, MD, MPH,b SYNOPSIS Led poisoning in children imposes

More information

Safety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA

Safety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,

More information

obesità nel bambino: epidemiologia e prevenzione

obesità nel bambino: epidemiologia e prevenzione Obesità, Nutrizione e Stili di vit. Trento 31 Mrzo 27 obesità nel bmbino: epidemiologi e prevenzione Cludio Mffeis Diprtimento Mterno Infntile e Biologi-Genetic Sezione di Peditri - Università di Veron

More information

Original Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:

Original Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract: Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute

More information

Presented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE

Presented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,

More information

Fertility in Norwegian testicular cancer patients

Fertility in Norwegian testicular cancer patients DOI: 0.054/ bjoc.999.0989, vilble online t http://www.idelibrry.com on Fertility in Norwegin testiculr cncer ptients SD Fosså nd Ø Krvdl 2 The Norwegin Rdium Hospitl, Montebello, N-030 Oslo, Norwy; 2 The

More information

Lifetime and 12-Month Prevalence of Psychiatric Disorders in 8,169 Male Vietnam War Era Veterans

Lifetime and 12-Month Prevalence of Psychiatric Disorders in 8,169 Male Vietnam War Era Veterans MILITARY MEDICINE, 169, 11:896, 2004 Lifetime nd 12-Month Prevlence of Psychitric Disorders in 8,169 Mle Vietnm Wr Er Veterns Gurntor: Seth A. Eisen, MD Contributors: Seth A. Eisen, MD* ; Kristin H. Griffith,

More information

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Surveillnce nd outbrek reports Drug resistnce mong tuberculosis cses in the Europen Union nd Europen Economic Are, 2007 to 2012 M J vn der Werf (mrieke.vnderwerf@ecdc.europ.eu) 1, C Ködmön 1, V Hollo 1,

More information

Utilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E

Utilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E Title Utiliztion of dentl services in Southern Chin Author(s) Lo, ECM; Lin, HC; Wng, ZJ; Wong, MCM; Schwrz, E Cittion Journl Of Dentl Reserch, 2001, v. 80 n. 5, p. 1471-1474 Issued Dte 2001 URL http://hdl.hndle.net/10722/53200

More information

phosphatase isoenzyme activity: estimation of

phosphatase isoenzyme activity: estimation of J Clin Pthol 1988;41:202-206 Quntittive method for determining serum lkline phosphtse isoenzyme ctivity: estimtion of intestinl component M J PEAKE, M PEJAKOVIC, G H WHITE From the Deprtment ofbiochemistry

More information

The Medium, Not the Message. How Tattoos Correlate With Early Mortality. Henry J. Carson, MD ABSTRACT

The Medium, Not the Message. How Tattoos Correlate With Early Mortality. Henry J. Carson, MD ABSTRACT The Medium, Not the Messge How Tttoos Correlte With Erly Mortlity Henry J. Crson, MD From Mercy Hospitl, Iow City, IA. Key Words: Tttooing; Autopsy; Forensic sciences; Violence; Suicide; Drug overdose

More information

Authors: Ms. Joanne Cassar, Ms. Natasha Sindicich and Dr. Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales.

Authors: Ms. Joanne Cassar, Ms. Natasha Sindicich and Dr. Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales. ecstsy nd relted drug trends july bulletin Authors: Ms. Jonne Cssr, Ms. Ntsh Sindicich nd Dr. Lucy Burns, Ntionl Drug nd Alcohol Reserch Centre, University of New South Wles. Suggested Cittion: Cssr, J.,

More information